Preview

International Marketing Plan for Blackmore's Cold and Flu

Powerful Essays
Open Document
Open Document
4700 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
International Marketing Plan for Blackmore's Cold and Flu
International marketing plan
Blackmores Cold and Flu

Table of contents

Executive Summary 3
Product description 4
Market Description 6
Market 6
OTC Medicine features 7
Main self-medication product groups 7
OTC categories in India 8
Comparison with competitors’ product 8
Direct and indirect competitors 8
Factors that make Blackmores stand out from its competitors? 9
Target market size 10
Government Participation 11
Marketing processes 12
Marketing objectives via new strategy of implementation 12
Product adaptation 15
Promotional mix 15
Advertising to the general public 15
Promotion via health care providers 16
Distribution from origin to destination 17
Channel management 17
Distribution processes 18
Price determination 19
Conclusion 21
References 22

Executive Summary

Choosing India as a destination to market Blackmores’ Cold/Flu Night & Day may seem radical; however the company has strong belief that this will benefit them not only in the short run, but in the long run too. India is reported to have one of the fasted growing pharmaceutical industries in the world with advanced technologies and many other contributing factors, which can be adopted by Blackmores to become a market leader in their industry.
Currently the industry is highly regulated; however trends seem to be changing. Factors contributing to this change are the sheer size and growth of Indian domestic pharmaceutical industry, which as a result makes it increasingly difficult for the government to regulate every firms. Secondly pressure being applied from World trade Organisation to speed up discussions within the national government to improve patent protection. This will result in providing foreign pharmaceutical firms being provided improved marketing opportunities in the Indian Enormous Drug market over years to come. Blackmores however would like to get a head start and move in to get a strong foothold in this industry by marketing the Cold/Flu Night And Day



References: Belch, G. & Belch, M. (2001) Advertising and Promotion, McGraw Hill, Australia Bhangale, V.(2007) Cateora, P. & Graham, J. (2009) International Marketing, McGraw Hill, Australia Czinkota, M Dumont, J-C. & Lemaitre, G. (2009) Counting Immigrants and expatriates in OECD COUNTRIES: A new perspective. Retrieved October 16, 2001, from http://www.oecd.org/dataoecd/27/5/33868740.pdf. Fletcher, R., Brown, L. (2008), International Marketing - An Asia Pacific Perspective, 4TH Edition, Prentice Hall, Australia Keegan, W Kotler, P. & Armstrong, G. (2006), Principles of marketing, 11th edition, Pearson Prentice Hall. Media Contact Resources Neoncarrot (2009). Indian Tourism Statistics. Retrieved October 16, 2001, from http://www.neoncarrot.co.uk/h_aboutindia/india_tourism_stats.html#touris . Pharmaceutical and drug manufacturers (2010). Pharma Industry Statistics. Retrieved October 16, 2001, from http://www.pharmaceutical-drug-manufacturers.com/pharma-industry-statistics/. William, G. (2007). The Emergence of India’s Pharmaceutical Industry and Implications for the US Generic

You May Also Find These Documents Helpful

  • Powerful Essays

    The Indian Pharmaceutical Industry is among top five producers of bulk drugs in the world. Pharmaceuticals market can be roughly classified into Bulk drugs (20% of the market) registering growth rates of 20% and formulations (80% of the market) with an annual growth rate of 15%.There are about 8174 bulk drug manufacturing units and 2389 formulations units spread across the country.…

    • 11559 Words
    • 47 Pages
    Powerful Essays
  • Better Essays

    In the The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and…

    • 8549 Words
    • 35 Pages
    Better Essays
  • Powerful Essays

    • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage…

    • 1400 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Prakriti Case Study

    • 1984 Words
    • 8 Pages

    Increase in the sale of OTC drugs in the recent years implies that people often forget the fact that health cannot be bought over the counter of pharmacy. Several forecasts state that the world OTC market will reach 4 92.8bn in the year 2015 with a strong growth until 2025. With Ayurveda based OTC’s contributing over 26% of sales, India ranks 11th in terms of OTC market size globally and is expected to reach 9th rank in the next five years.…

    • 1984 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    Gst India

    • 4625 Words
    • 19 Pages

    During my study I also analysed the prospects on India as a manufacturing hub for pharmaceutical industries. The possibilities and advantages of having pharmaceutical manufacturing centres in India were also explored.…

    • 4625 Words
    • 19 Pages
    Powerful Essays
  • Good Essays

    Repositioning Ranbaxy

    • 897 Words
    • 4 Pages

    The Indian market was governed by price controls in the 1970s and 1980s – a situation that did not incentivise research. This, coupled with low per capita income resulted in demand for drugs that was not very high in sophistication. The bias for small scale resulted in over-capacity that led to excessive price competition. This kind of rivalry in the domestic market prompted Ranbaxy to adopt a differentiation strategy. Ranbaxy tried to create differentiation through Marketing and Process Technology. This resulted in improved product/brand profitability, and an increase in brand life cycle, similar to the post-patent approach adopted by many research-based companies. At about the same time, Ranbaxy embarked on an export drive. This gave Ranbaxy improved margins, an entry-point into several international markets, and an opportunity to spread its risks away from the controlled Indian market. Without doubt Ranbaxy was blessed with benign factor conditions: significant cost advantages in R&D and in manufacturing. The role of supporting industries was not very significant as import of bulk drugs, that were not produced domestically, was allowed by the Indian government…

    • 897 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    Currently, the Canadian company has good opportunity to export their medicine to because both the countries have good economic relations. Both countries view each other as complementary economies. It could enhance their own competitiveness by integrating themselves in the global supply chain by taking advantage of India’s low-cost skilled labour. The existence of English as the common language of business should enable the Canadian company to find a suitable sales agent who would handle the marketing of its product in the foreign market (India) (Canada Service Coalition, 2007).If the Canadian company chooses exporting as their entry mode the advantages it may obtain is increased profits, reduce the risk & balance growth, Lower the unit cost and economies of scale. Another advantage…

    • 433 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Ranbaxy Laboratories

    • 8012 Words
    • 33 Pages

    Product patent regime implemented in India from Jan 2005 compelled Indian pharma companies to relook in to their marketing strategies so as to become competitive & strongly withstand in the competition with MNC’s & big giants in domestic markets. Product patent regime posed Indian pharmaceutical companies to change their strategies. If the Indian…

    • 8012 Words
    • 33 Pages
    Powerful Essays
  • Powerful Essays

    Preface India is fast emerging as a favoured destination for clinical trials by global pharmaceutical and biotech companies that are looking for partnerships or setting up new operations. Two major reasons for its popularity are: easy access and availability of a large, diverse and therapy-naïve population with vast gene pool and lower cost of technical services resulting into lower per patient trial cost. India also has the advantage of having a large pool of highly trained physicians, nurses, and technical personnel; numerous world-class medical facilities; broadly developed information technology infrastructure; a favourable IPR environment (post signing the WTO agreement) and use of English as the primary business and medical language. The total value of clinical research performed in India in 2004-05 was about US$100 million. The major companies involved in Clinical research in India have a wide range of services to offer. Thus, the industry needs to know the companies operating in this field. The directory of ‘Clinical Research Companies in India’ is the answer to it…

    • 1390 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Ananlysis Dr. Reddy's Lab

    • 1106 Words
    • 5 Pages

    • After this extraordinary achievement of bein first Indian company to expand overseas, Dr. Reddy, formed four pillar based strategy comprising - product diversification, international expansion with branded formulation, & growth in Generic businesses. It was also well supplemented by efforts in building of capabilities in new drug discoveries to set required vision in front of the rapidly growing organization. This is considering the overall vision of Dr. Reddy himself who wanted not only acquire wealth but also quench his thrust of doing R&D in chemical sector.…

    • 1106 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    1. Indust ry Overview The pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S., U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies (annual revenues USD 1,000 million and above) worldwide The global pharmaceutical industry is estimated to be about 50. This report gives a brief end of 2010 with a growth rate of description on the global pharmaceutical market’s size, around 5 to 6 percent. trends, issues, challenges and critical success factors etc. The report also elaborates on the profile of the major players in the global pharmaceutical market. The global pharmaceutical industry is expected to reach $830 billion by 2010 with a growth rate of around 5 to 6 percent. While the pharmaceutical industry in regions like Latin America, Europe and Japan is growing at a steady rate which is more are less equal to that of the overall industry, the developing regions like China and India are recording corresponding growth in double figures. Industry analysts predict that the pharmaceutical market would reach $1.1 trillion by 2015 with the average growth rate of around 7 percent. United States is still the largest pharmaceuticals market in the world with a market size of around $300 billion and it is expected to reach $370 to $390 billion by 2015. The developing countries like China, India and Brazil still need to go a long way to reach the level of operations of the developed countries. As the developing countries are growing at the rate of 15 to 16 percent, there is a huge scope for the development of generic drugs there.…

    • 4463 Words
    • 18 Pages
    Powerful Essays
  • Powerful Essays

    The lack of patent protection made the Indian market undesirable to the multinational companies that had dominated the market, and while they streamed out. Indian companies carved a niche in both the Indian and world markets with their expertise in reverse-engineering new processes for manufacturing drugs at low costs. Although some of the larger companies have taken baby steps towards drug innovation, the industry as a whole has been following this business model until the present.…

    • 11914 Words
    • 48 Pages
    Powerful Essays
  • Better Essays

    India is poised to be one of the fastest growing pharmaceutical markets in the world. This has led to entry of many major companies in the Indian market and a huge amount of FDI inflow.…

    • 4261 Words
    • 18 Pages
    Better Essays
  • Satisfactory Essays

    Eli and Lilly

    • 462 Words
    • 2 Pages

    The country was right. Even though India was characterized by low per capita GDP, but the population of India cannot be ignored. And 200 million and 300 million of 800 million people in India were middle class. That was a huge potential market for Eli Lilly and Company. As the cost of health-care increased in developed countries in the 1990s, chose India was a good choice for a international company like Eli and Lilly. Especially could uses India as trade route to export products to Russia, so choose India had a lot of advantages.…

    • 462 Words
    • 2 Pages
    Satisfactory Essays
  • Best Essays

    Pfizer Competitor Analysis

    • 3793 Words
    • 16 Pages

    The value that the branded pharmaceutical industry adds to the US economy is growing slower than US GDP (Snyder, 2012). Rivalry has intensified while the rate of blockbuster drug development has slowed due to an increase in regulation from the government and the industry trade association, PhRMA. The number of new entrants is fairly low and some are exiting or consolidating through mergers and acquisitions. Downstream and upstream factors are crucial to the specialty pharmaceutical sector of this industry since supply and distribution are different than in traditional branded pharmaceuticals. Complementors such as antiemetics and substitutes such as marijuana and acupuncture exist but currently do not play a large enough role to affect rivalry.…

    • 3793 Words
    • 16 Pages
    Best Essays